KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

Trading levels for CLRB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.18 5.06 %
R2 3.13 3.29 %
R1 3.10 2.20 %
Current price: 3.03
Support S1 2.99 -1.32 %
S2 2.96 -2.41 %
S3 2.90 -4.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.78 24.75 %
R2 3.50 15.51 %
R1 3.49 15.18 %
Current price 3.03
Support S1 3.02 -0.330%
S2 0 .
S3 0 .

CLRB Predictions History

4 years ago
JS predicted that CLRB for 2020-02-14 is going $3.02 (3.07%)

4 years ago
Clint K predicted that CLRB for 2020-02-14 is going

Rank:

4 years ago
Sarah.Fitzpatrick.109128 predicted that CLRB for 2019-05-20 is going $2.31 (15.50%)

Rank:

5 years ago
NameNotImportant predicted that CLRB for 2019-04-29 is going $2.22 (-3.48%)

6 years ago
JS predicted that CLRB for 2017-09-18 is going $1.82 (1.68%)

6 years ago
JS predicted that CLRB for 2017-06-12 is going $1.70 (3.03%)

6 years ago
Jon predicted that CLRB for 2017-06-12 is going $1.61 (-2.42%)

6 years ago
Ahmad predicted that CLRB for 2017-06-12 is going $1.77 (7.27%)

Rank:

7 years ago
Stefan.Taranu.5043 predicted that CLRB for 2017-03-28 is going $2.39 (4.82%)

Rank:

7 years ago
JS predicted that CLRB for 2017-03-28 is going $2.45 (7.46%)

Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT